WallStSmart
XBIO

Xenetic Biosciences Inc

NASDAQ: XBIO · HEALTHCARE · BIOTECHNOLOGY

$3.03
+1.00% today

Updated 2026-04-30

Market cap
$6.87M
P/E ratio
P/S ratio
2.31x
EPS (TTM)
$-1.58
Dividend yield
52W range
$2 – $14
Volume
0.0M

WallStSmart proprietary scores

32
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+
5.0
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$40.00
+1220.13%
12-Month target
Intrinsic (DCF)
$12.86
Margin of safety
+83.36%

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 18.10% QoQ
+ 83.36% below intrinsic value
Risks
- Thin margins at -90.10%
- Negative free cash flow $-242682.00

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$1.71M$2.54M$2.50M$2.98M$2.98M
Net income$-6.55M$-4.13M$-3.96M$-2.68M$-579076.00
EPS$-1.58
Free cash flow$-5.15M$-4.11M$-2.82M$-2.29M$-242682.00
Profit margin-383.87%-162.78%-158.39%-90.07%-90.10%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
XBIO$6.87M327.32.06.75.0+83.36%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Xenetic Biosciences Inc trades at $3.03. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $2.98M. with profit margins at -90.10%. Our DCF model estimates intrinsic value at $12.86.

Frequently asked questions

What is Xenetic Biosciences Inc's stock price?
Xenetic Biosciences Inc (XBIO) trades at $3.03.
Is Xenetic Biosciences Inc overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell). DCF value $12.86.
What is the price target of Xenetic Biosciences Inc (XBIO)?
The analyst target price is $40.00, representing +1220.1% upside from the current price of $3.03.
What is the intrinsic value of Xenetic Biosciences Inc (XBIO)?
Based on our DCF model, intrinsic value is $12.86, a +83.4% margin of safety versus $3.03.
What is Xenetic Biosciences Inc's revenue?
TTM revenue is $2.98M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio2.31x
ROE-40.00%
Beta2.21
50D MA$2.86
200D MA$2.96
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years